1st Quarter - Report

EISAI INC. for EISAI INC.

Firm
Client
Income
—
Expenses
$860,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

DoD/TRICARE coverage of obesity medications * NAtional Defense Authorization Bill for 2015

LobbyistCovered position, as disclosed
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Medicare/Medicaid MMM

Medicare coverage of obesity medications * H.R. 2415/S. 1184 -- Treat and Reduce Obesity Act

LobbyistCovered position, as disclosed
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 2415 (113th), S. 1184 (113th)

Budget/Appropriations BUD

Potential pharmaceutical reimbursement cuts (offsets) and potential inclusion of Medicare coverage of obesity Rx products * HR 3547 -- FY 2014 Omnibus * HJRes 106 -- Continuing Resolution -- PL 113-73 * HJRes 59 -- Continuing Resolution -- PL 113-67

LobbyistCovered position, as disclosed
STEPHEN D MCMILLAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3547 (113th), H.J.Res. 106 (113th), H.J.Res. 59 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.